Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2026-01-25 @ 8:29 AM
Study NCT ID:
NCT03468751
Status:
UNKNOWN
Last Update Posted:
2020-06-01
First Post:
2018-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors
Sponsor:
Henlix, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HLX10-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None